Genome mining as a biotechnological tool for the discovery of novel biosynthetic genes in lichens.

IF 2.1 Q3 MYCOLOGY
Frontiers in fungal biology Pub Date : 2022-10-03 eCollection Date: 2022-01-01 DOI:10.3389/ffunb.2022.993171
Garima Singh, Francesco Dal Grande, Imke Schmitt
{"title":"Genome mining as a biotechnological tool for the discovery of novel biosynthetic genes in lichens.","authors":"Garima Singh,&nbsp;Francesco Dal Grande,&nbsp;Imke Schmitt","doi":"10.3389/ffunb.2022.993171","DOIUrl":null,"url":null,"abstract":"<p><p>Natural products (NPs) and their derivatives are a major contributor to modern medicine. Historically, microorganisms such as bacteria and fungi have been instrumental in generating drugs and lead compounds because of the ease of culturing and genetically manipulating them. However, the ever-increasing demand for novel drugs highlights the need to bioprospect previously unexplored taxa for their biosynthetic potential. Next-generation sequencing technologies have expanded the range of organisms that can be explored for their biosynthetic content, as these technologies can provide a glimpse of an organism's entire biosynthetic landscape, without the need for cultivation. The entirety of biosynthetic genes can be compared to the genes of known function to identify the gene clusters potentially coding for novel products. In this study, we mine the genomes of nine lichen-forming fungal species of the genus <i>Umbilicaria</i> for biosynthetic genes, and categorize the biosynthetic gene clusters (BGCs) as \"associated product structurally known\" or \"associated product putatively novel\". Although lichen-forming fungi have been suggested to be a rich source of NPs, it is not known how their biosynthetic diversity compares to that of bacteria and non-lichenized fungi. We found that 25%-30% of biosynthetic genes are divergent as compared to the global database of BGCs, which comprises 1,200,000 characterized biosynthetic genes from plants, bacteria, and fungi. Out of 217 BGCs, 43 were highly divergant suggesting that they potentially encode structurally and functionally novel NPs. Clusters encoding the putatively novel metabolic diversity comprise polyketide synthases (30), non-ribosomal peptide synthetases (12), and terpenes (1). Our study emphasizes the utility of genomic data in bioprospecting microorganisms for their biosynthetic potential and in advancing the industrial application of unexplored taxa. We highlight the untapped structural metabolic diversity encoded in the lichenized fungal genomes. To the best of our knowledge, this is the first investigation identifying genes coding for NPs with potentially novel properties in lichenized fungi.</p>","PeriodicalId":73084,"journal":{"name":"Frontiers in fungal biology","volume":"3 ","pages":"993171"},"PeriodicalIF":2.1000,"publicationDate":"2022-10-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10512267/pdf/","citationCount":"4","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in fungal biology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3389/ffunb.2022.993171","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"MYCOLOGY","Score":null,"Total":0}
引用次数: 4

Abstract

Natural products (NPs) and their derivatives are a major contributor to modern medicine. Historically, microorganisms such as bacteria and fungi have been instrumental in generating drugs and lead compounds because of the ease of culturing and genetically manipulating them. However, the ever-increasing demand for novel drugs highlights the need to bioprospect previously unexplored taxa for their biosynthetic potential. Next-generation sequencing technologies have expanded the range of organisms that can be explored for their biosynthetic content, as these technologies can provide a glimpse of an organism's entire biosynthetic landscape, without the need for cultivation. The entirety of biosynthetic genes can be compared to the genes of known function to identify the gene clusters potentially coding for novel products. In this study, we mine the genomes of nine lichen-forming fungal species of the genus Umbilicaria for biosynthetic genes, and categorize the biosynthetic gene clusters (BGCs) as "associated product structurally known" or "associated product putatively novel". Although lichen-forming fungi have been suggested to be a rich source of NPs, it is not known how their biosynthetic diversity compares to that of bacteria and non-lichenized fungi. We found that 25%-30% of biosynthetic genes are divergent as compared to the global database of BGCs, which comprises 1,200,000 characterized biosynthetic genes from plants, bacteria, and fungi. Out of 217 BGCs, 43 were highly divergant suggesting that they potentially encode structurally and functionally novel NPs. Clusters encoding the putatively novel metabolic diversity comprise polyketide synthases (30), non-ribosomal peptide synthetases (12), and terpenes (1). Our study emphasizes the utility of genomic data in bioprospecting microorganisms for their biosynthetic potential and in advancing the industrial application of unexplored taxa. We highlight the untapped structural metabolic diversity encoded in the lichenized fungal genomes. To the best of our knowledge, this is the first investigation identifying genes coding for NPs with potentially novel properties in lichenized fungi.

Abstract Image

Abstract Image

Abstract Image

基因组挖掘作为在地衣中发现新的生物合成基因的生物技术工具。
天然产物及其衍生物是现代医学的主要贡献者。从历史上看,细菌和真菌等微生物在产生药物和铅化合物方面发挥了重要作用,因为它们易于培养和基因操纵。然而,对新药日益增长的需求突出表明,需要对以前未探索的分类群进行生物勘探,以了解其生物合成潜力。下一代测序技术扩大了可以探索其生物合成含量的生物体的范围,因为这些技术可以在不需要培养的情况下提供生物体整个生物合成景观的一瞥。可以将整个生物合成基因与具有已知功能的基因进行比较,以识别潜在编码新产品的基因簇。在这项研究中,我们挖掘了9种脐属地衣形成真菌的基因组中的生物合成基因,并将生物合成基因簇(BGCs)归类为“结构已知的相关产物”或“推定新颖的相关产物。尽管地衣形成真菌被认为是NP的丰富来源,但尚不清楚它们的生物合成多样性与细菌和非地衣化真菌相比如何。我们发现,与全球BGC数据库相比,25%-30%的生物合成基因是不同的,该数据库包括来自植物、细菌和真菌的1200000个特征生物合成基因。在217个BGC中,有43个是高度分化的,这表明它们可能编码结构和功能上新颖的NP。编码假定的新代谢多样性的簇包括聚酮合成酶(30)、非核糖体肽合成酶(12)和萜烯(1)。我们的研究强调了基因组数据在生物勘探微生物生物合成潜力和推进未探索分类群工业应用方面的实用性。我们强调了地衣化真菌基因组中编码的未开发的结构代谢多样性。据我们所知,这是首次在地衣化真菌中鉴定具有潜在新特性的NP编码基因。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
2.70
自引率
0.00%
发文量
0
审稿时长
13 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信